Susceptibility to SARS‐Cov‐2 infection and risk for severe COVID‐19 in patients with prostate cancer on androgen deprivation therapy

Androgen deprivation therapy (ADT) has been hypothesized to protect against COVID‐19, but previous observational studies of men with prostate cancer on ADT have been inconsistent regarding mortality risk from coronavirus disease 2019 (COVID‐19). Using data from the Prostate Cancer data Base Sweden (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gedeborg, Rolf, Loeb, Stacy, Styrke, Johan, Kiiski‐Berggren, Ritva, Garmo, Hans, Stattin, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349425/
https://www.ncbi.nlm.nih.gov/pubmed/35802468
http://dx.doi.org/10.1002/ijc.34204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349425/
https://www.ncbi.nlm.nih.gov/pubmed/35802468
http://dx.doi.org/10.1002/ijc.34204

Ejemplares similares